Steamboat Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-102,365
Closed -$6.17M 40
2020
Q3
$6.17M Sell
102,365
-1,271
-1% -$76.5K 1.01% 36
2020
Q2
$6.09M Sell
103,636
-17,037
-14% -$1.02M 1.13% 31
2020
Q1
$6.73M Buy
120,673
+683
+0.6% +$41.7K 1.32% 32
2019
Q4
$7.7M Buy
+119,990
New +$6.87M 2.18% 21

Other funds holding BMY

Steamboat Capital Partners's BMY Position: Q4 2020 in Review

Steamboat Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 102,365 shares — an estimated $6.17M sold.

Steamboat Capital Partners first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $7.7M in Q4 2019. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Steamboat Capital Partners reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Steamboat Capital Partners sold 102,365 Bristol-Myers Squibb shares in Q4 2020, an estimated $6.17M.
  • Steamboat Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
  • Steamboat Capital Partners's Bristol-Myers Squibb position peaked at $7.7M in Q4 2019.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Steamboat Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.